About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Trp53tm1Gev
targeted mutation 1, Gerard I Evan
MGI:3582594
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Trp53tm1Gev/Trp53tm1Gev involves: 129P2/OlaHsd * C57BL/6 MGI:3582657
cn2
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm1Gev/Trp53tm1Gev
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N MGI:5635880
cx3
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
Trp53tm1Gev/Trp53+
B6.Cg-Trp53tm1Gev Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd MGI:6378452


Genotype
MGI:3582657
hm1
Allelic
Composition
Trp53tm1Gev/Trp53tm1Gev
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53tm1Gev mutation (0 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• high incidence and spectrum of spontaneous lymphoma
• most are lymphoid in nature, mainly malignant and metastatic thymic lymphomas

cellular
• spleen, thymus and small intestinal epithelium exhibited gamma-irradiation induced apoptosis
• intraperitoneal administration of 4-hydrozytamoxifen restored radiosensitivity in as little as two hours

endocrine/exocrine glands
• high incidence and spectrum of spontaneous lymphoma
• most are lymphoid in nature, mainly malignant and metastatic thymic lymphomas




Genotype
MGI:5635880
cn2
Allelic
Composition
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm1Gev/Trp53tm1Gev
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm4Tyj mutation (9 available); any Kras mutation (76 available)
Tg(Pdx1-cre)6Tuv mutation (3 available)
Trp53tm1Gev mutation (0 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice exhibit rapid development of pancreatic tumors within 8 weeks with features typical of human pancreatic adenocarcinoma
• tumors treated with ibrutinib show a reduction in proliferation rate and tumor fibrosis, inhibition of mast cell degranulation, and reduction in CD11b+ and F4/80+ macrophages and mice show increased survival
• mice treated with both ibrutinib and gemcitabine show extended survival compared to treatment with gemcitabine alone
• mice treated with a daily injection of cromolyn, a blocker of mast cell degranulation and inflammogen release, starting at 8 weeks of age show a reduction in F4/80+ cells and CD11b+ cells in the tumor stroma

endocrine/exocrine glands
• mice exhibit rapid development of pancreatic tumors within 8 weeks with features typical of human pancreatic adenocarcinoma
• tumors treated with ibrutinib show a reduction in proliferation rate and tumor fibrosis, inhibition of mast cell degranulation, and reduction in CD11b+ and F4/80+ macrophages and mice show increased survival
• mice treated with both ibrutinib and gemcitabine show extended survival compared to treatment with gemcitabine alone
• mice treated with a daily injection of cromolyn, a blocker of mast cell degranulation and inflammogen release, starting at 8 weeks of age show a reduction in F4/80+ cells and CD11b+ cells in the tumor stroma

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
pancreatic carcinoma DOID:4905 OMIM:260350
J:220300




Genotype
MGI:6378452
cx3
Allelic
Composition
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
Trp53tm1Gev/Trp53+
Genetic
Background
B6.Cg-Trp53tm1Gev Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col1a1tm1(tetO-URI1)Ndj mutation (0 available); any Col1a1 mutation (160 available)
Tg(Cebpb-tTA)#Bjd mutation (0 available)
Trp53tm1Gev mutation (0 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice exhibit reduced survival compared to heterozygous Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd/0 mice

neoplasm
• mice exhibit accelerated liver tumorigenesis compared to single heterozygous Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd/0 mice, with 80% of mice showing aggressive hepatocellular carcinoma

liver/biliary system
• 8 week old mice show decreased cleaved caspase 3, Bax expression, collapsed fibers, Sirius Red staining and alanine transaminase levels, indicating suppressed hepatocyte apoptosis
• mice exhibit accelerated liver tumorigenesis compared to single heterozygous Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd/0 mice, with 80% of mice showing aggressive hepatocellular carcinoma

cellular
• 8 week old mice show decreased cleaved caspase 3, Bax expression, collapsed fibers, Sirius Red staining and alanine transaminase levels, indicating suppressed hepatocyte apoptosis





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory